Decreased α-cell mass and early structural alterations of the exocrine pancreas in patients with type 1 diabetes: An analysis based on the nPOD repository

Background and aims Abnormal glucagon secretion and functional alterations of the exocrine pancreas have been described in patients with type 1 diabetes (T1D), but their respective anatomical substrata have seldom been investigated. Our aim was to develop an automated morphometric analysis process to characterize the anatomy of α-cell and exocrine pancreas in patients with T1D, using the publicly available slides of the Network for Pancreatic Organ Donors (nPOD). Materials and methods The ratio of β- and α-cell area to total tissue area were quantified in 75 patients with T1D (thereafter patients) and 66 control subjects (thereafter controls), on 2 insulin-stained and 4 glucagon-stained slides from both the head and the tail of the pancreas. The β- and α-cell masses were calculated in the 66 patients and the 50 controls for which the pancreas weight was available. Non-exocrine-non-endocrine tissue area (i.e. non-acinar, non-insular tissue) to total tissue area ratio was evaluated on both insulin- and glucagon-stained slides. Results were expressed as mean ±SD. Results An automated quantification method was set up using the R software and was validated by quantification of β-cell mass, a well characterized parameter. β-cell mass was 29.6±112 mg in patients and 628 ±717 mg in controls (p<0.0001). α-cell mass was 181±176 mg in patients and 349 ±241mg in controls (p<0.0001). Non-exocrine-non-endocrine area to total tissue area ratio was 39±9% in patients and 29± 10% in controls (p<0.0001) and increased with age in both groups, with no correlation with diabetes duration in patients. Conclusion The absolute α-cell mass was lower in patients compared to controls, in proportion to the decrease in pancreas weight observed in patients. Non-exocrine-non-endocrine area to total tissue area ratio increased with age in both groups but was higher in patients at all ages.

[1]  O. Korsgren,et al.  Aetiology of type 1 diabetes: Physiological growth in children affects disease progression , 2018, Diabetes, obesity & metabolism.

[2]  A. Garg,et al.  Diabetes Mellitus in Living Pancreas Donors: Use of Integrated National Registry and Pharmacy Claims Data to Characterize Donation-Related Health Outcomes , 2017, Transplantation.

[3]  T. Hansen,et al.  Insulin Resistance Is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation , 2016, Diabetes.

[4]  H. Itoh,et al.  Effects of Obesity and Diabetes on α- and β-Cell Mass in Surgically Resected Human Pancreas , 2016, The Journal of clinical endocrinology and metabolism.

[5]  C. Boitard,et al.  β-cell Mass in Nondiabetic Autoantibody-Positive Subjects: An Analysis Based on the Network for Pancreatic Organ Donors Database. , 2016, The Journal of clinical endocrinology and metabolism.

[6]  J. Holst,et al.  Evidence of Extrapancreatic Glucagon Secretion in Man , 2015, Diabetes.

[7]  M. Atkinson,et al.  Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes , 2015, Diabetes.

[8]  J. Shuster,et al.  The influence of type 1 diabetes on pancreatic weight , 2015, Diabetologia.

[9]  C. Pipper,et al.  The influence of glucagon on postprandial hyperglycaemia in children 5 years after onset of type 1 diabetes , 2015, Diabetologia.

[10]  M. V. von Herrath,et al.  Erratum. Increased Immune Cell Infiltration of the Exocrine Pancreas: A Possible Contribution to the Pathogenesis of Type 1 Diabetes. Diabetes 2014;63:3880–3890 , 2014, Diabetes.

[11]  B. Zinman,et al.  Glucagon Response to Oral Glucose Challenge in Type 1 Diabetes: Lack of Impact of Euglycemia , 2014, Diabetes Care.

[12]  R. Rizza,et al.  β-Cell Mass and Turnover in Humans , 2012, Diabetes Care.

[13]  M. Atkinson,et al.  Network for Pancreatic Organ Donors with Diabetes (nPOD): developing a tissue biobank for type 1 diabetes , 2012, Diabetes/metabolism research and reviews.

[14]  C. Boitard,et al.  Pancreatic exocrine function in patients with diabetes , 2012, Diabetic medicine : a journal of the British Diabetic Association.

[15]  P. Cryer Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes. , 2012, Endocrinology.

[16]  A. Cherrington,et al.  Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover. , 2012, The Journal of clinical investigation.

[17]  R. Rizza,et al.  b-Cell Mass and Turnover in Humans Effects of obesity and aging , 2012 .

[18]  J. Henquin,et al.  Pancreatic alpha cell mass in European subjects with type 2 diabetes , 2011, Diabetologia.

[19]  C. Boitard,et al.  Pancreatic Volume and Endocrine and Exocrine Functions in Patients With Diabetes , 2011, Pancreas.

[20]  S. Riddell,et al.  The emperor of all maladies: A biography of cancer , 2011 .

[21]  J. Gaglia,et al.  Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients. , 2011, The Journal of clinical investigation.

[22]  C. Sempoux,et al.  Pancreatic β‐cell mass in European subjects with type 2 diabetes , 2008, Diabetes, obesity & metabolism.

[23]  E. Seaquist,et al.  Risk of Glucose Intolerance and Diabetes in Hemipancreatectomized Donors Selected for Normal Preoperative Glucose Metabolism , 2008, Diabetes Care.

[24]  K. Rother,et al.  Too Much Glucagon, Too Little Insulin , 2008, Diabetes Care.

[25]  Victor Couture,et al.  Appendix for online publication , 2007 .

[26]  A. Imagawa,et al.  Histopathologic Study of Lymphocytic Infiltration the Pancreas Shows in Japanese Patients a Characterist with IDDM , 2006 .

[27]  R. Goebbels,et al.  Cellular composition of the human diabetic pancreas , 1983, Diabetologia.

[28]  P. Cryer,et al.  Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response. , 2002, Diabetes.

[29]  Emma Altobelli,et al.  Size of pancreas in children and adolescents with type I (insulin‐dependent) diabetes , 1998, Journal of clinical ultrasound : JCU.

[30]  Y. Matsuzawa,et al.  Histopathologic study of the pancreas shows a characteristic lymphocytic infiltration in Japanese patients with IDDM. , 1997, Endocrine journal.

[31]  E. Seaquist,et al.  Effects of hemipancreatectomy on pancreatic alpha and beta cell function in healthy human donors. , 1992, The Journal of clinical investigation.

[32]  J. Najarian,et al.  Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. , 1990, The New England journal of medicine.

[33]  P. Dandona,et al.  Size of pancreas in diabetes mellitus: a study based on ultrasound. , 1985, British medical journal.

[34]  L. Orci,et al.  Demonstration of Glucagon in the Stomach of Human Fetuses , 1981, Diabetes.

[35]  L. Orci,et al.  Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J. Gerich,et al.  Lack of Glucagon Response to Hypoglycemia in Diabetes: Evidence for an Intrinsic Pancreatic Alpha Cell Defect , 1973, Science.

[37]  W. A. Müller,et al.  Studies of pancreatic alpha cell function in normal and diabetic subjects. , 1970, The Journal of clinical investigation.